Sigurdur O. Olafsson
President and CEO, Director · Keenova Therapeutics plc
- 2025
- Feb 27, 2026
- 3
Summary
Latest filing:
Sigurdur O. Olafsson has 3 SEC Form 4 filings on record going back to 2025, most recently on 27 February 2026.
Trading pattern
InsiderAlpha's records for Sigurdur O. Olafsson go back to 2025: 3 primary Form 4 filings, an average of 1.5 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
Most active insiders across the market
Sigurdur O. Olafsson has no co-filers on record, so these are insiders with the largest open-market activity across the market in the last 90 days.
- Ronald N. Tutor - $197.71M in TPC purchases and sales in the last 90 days
- NIPPON LIFE INSURANCE CO - $194.45M in CRBG purchases and sales in the last 90 days
- Paul R. Vigano - $192.63M in AVAH purchases and sales in the last 90 days
- Robert M. Williams Jr. - $192.63M in AVAH purchases and sales in the last 90 days
- Sean Lie - $192.09M in CBRS purchases and sales in the last 90 days
- August J. Troendle - $190.85M in MEDP purchases and sales in the last 90 days
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Sigurdur O. Olafsson?
Sigurdur O. Olafsson is a corporate insider, tracked as President and CEO, Director. InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Sigurdur O. Olafsson last file a Form 4?
The most recent primary Form 4 on record is dated 27 February 2026, one of 3 filings going back to 2025.
Learn more
No Form 4 transactions on record for Sigurdur O. Olafsson yet.
Filings appear here automatically as they arrive from SEC EDGAR.